Cold, Flu & Cough News and Research

Latest Cold, Flu & Cough News and Research

Meningitis Now urges schools to protect pupils from deadly meningitis

LEADING UK meningitis charity, Meningitis Now, is calling on headteachers to ensure pupils are protected from deadly meningitis.

27 Jan 2016

New case of MERS CoV confirmed in Thailand, other states in WHO South-East Asia Region cautioned to remain vigilant

Thailand today confirmed Middle East respiratory syndrome coronavirus disease in a traveler, the second such case in the country in the last seven months, as WHO cautioned other member states in its South-East Asia Region against the continuing risks and the need to remain vigilant.

27 Jan 2016

E-cigarettes suppress immune defenses, alter inflammation and boost bacterial virulence

Researchers at the University of California, San Diego School of Medicine and Veterans Affairs San Diego Healthcare System report data suggesting that e-cigarettes are toxic to human airway cells, suppress immune defenses and alter inflammation, while at the same time boosting bacterial virulence.

27 Jan 2016

Panasonic introduces new -40°C freezer with hydrocarbon refrigerant

New MDF-U5412H -40°C Freezers from Panasonic, with hydrocarbon refrigerants for increased efficiency, provide the ideal stable and uniform storage environment for the preservation of plasma

From PHC Europe B.V. 26 Jan 2016

Building Health Check launches IAQ Screening Kit for E. coli bacteria

Following a number of recent outbreaks of E. coli, or Escherichia coli, bacteria at grocers and restaurants across the country, Building Health Check, LLC, has released an Indoor Air Quality (IAQ) Screening Kit for the E. coli bacteria.

26 Jan 2016

Chronic fatigue syndrome affects almost 2% of 16-year-olds

In what is believed to be the biggest study of chronic fatigue syndrome (CFS) -- also known as myalgic encephalomyelitis (ME) -- in children to date, researchers at the University of Bristol (UK), have found that almost 2 per cent of 16-year-olds have CFS lasting more than six months and nearly 3 per cent have CFS lasting more than three months (the UK definition).

25 Jan 2016

Carbapenem-resistant Enterobacteriaceae: an interview with Dr. Michael Dudley

Enterobacteriaceae refer to the family of bacteria such as E. coli and Klebsiella that are bacterial pathogens most frequently associated with hospital-acquired infections

25 Jan 2016

UC San Diego researchers develop rapid susceptibility test for Staphylococcus aureus

A team of biologists and biomedical researchers at UC San Diego has developed a new method to determine if bacteria are susceptible to antibiotics within a few hours, an advance that could slow the appearance of drug resistance and allow doctors to more rapidly identify the appropriate treatment for patients with life threatening bacterial infections.

25 Jan 2016

Positive bosutinib response for elderly blast phase CML patient

A case study suggests that the third-generation tyrosine kinase inhibitor bosutinib may be considered as induction therapy for blast phase chronic myeloid leukaemia in older patients.

22 Jan 2016

New interprofessional program aims to provide primary care and dental services to older adults

Primary care within a dental practice? It's an interdisciplinary idea that has teeth: Your mouth, noted the U.S. surgeon general in the Oral Health in America report, provides a window into your overall health. Now, a research team led by Maria Dolce, an associate professor in the School of Nursing at Northeastern, will make that idea a reality.

22 Jan 2016

Oral drug ivacaftor appears to be safe, beneficial to pre-school children with specific type of cystic fibrosis

The oral drug ivacaftor appears to be safe and could be beneficial to young children between the ages of 2 and 5 with a specific type of cystic fibrosis, according to new research published in The Lancet Respiratory Medicine journal.

22 Jan 2016

Amgen announces approval of cholesterol-lowering medication Repatha (evolocumab) Injection in Japan

Amgen today announced that the Japanese Ministry of Health, Labour and Welfare has approved the cholesterol-lowering medication Repatha (evolocumab) Injection, the first proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitor to be approved in Japan.

22 Jan 2016

Duke researchers closer to developing rapid blood test for bacterial and viral infections

Researchers at Duke Health are fine-tuning a test that can determine whether a respiratory illness is caused by infection from a virus or bacteria so that antibiotics can be more precisely prescribed.

21 Jan 2016

Immunotherapy could be the future of cancer treatments

For decades most cancers have been treated with the standard of care treatments which typically include surgery, radiation and/or chemotherapy. Now there is talk that immunotherapy represents "the future of cancer treatments."

21 Jan 2016

NSSA offers tips to avoid winter sports injuries

If you're suited up and ready to ski or snowboard, you're not alone. These popular sports draw more than 9.5 million participants a year, according to the National Ski Areas Association, and they accounted for 53.6 million total skier and snowboarder visits to ski areas in the 2014-15 season.

21 Jan 2016

Adding naturally-occurring protein to flu vaccine may offer protection to babies

According to the World Health Organization, influenza causes serious illness among millions of people each year, resulting in 250,000 to 500,000 deaths. Those most at risk include infants younger than six months, because they cannot be vaccinated against the disease.

20 Jan 2016

Cold, Flu & Cough News and Research

Latest Cold, Flu & Cough News and Research

Meningitis Now urges schools to protect pupils from deadly meningitis

New case of MERS CoV confirmed in Thailand, other states in WHO South-East Asia Region cautioned to remain vigilant

E-cigarettes suppress immune defenses, alter inflammation and boost bacterial virulence

Panasonic introduces new -40°C freezer with hydrocarbon refrigerant

Building Health Check launches IAQ Screening Kit for E. coli bacteria

Chronic fatigue syndrome affects almost 2% of 16-year-olds

Carbapenem-resistant Enterobacteriaceae: an interview with Dr. Michael Dudley

UC San Diego researchers develop rapid susceptibility test for Staphylococcus aureus

Positive bosutinib response for elderly blast phase CML patient

New interprofessional program aims to provide primary care and dental services to older adults

Oral drug ivacaftor appears to be safe, beneficial to pre-school children with specific type of cystic fibrosis

Amgen announces approval of cholesterol-lowering medication Repatha (evolocumab) Injection in Japan

Duke researchers closer to developing rapid blood test for bacterial and viral infections

Immunotherapy could be the future of cancer treatments

NSSA offers tips to avoid winter sports injuries

Adding naturally-occurring protein to flu vaccine may offer protection to babies

Estrogen helps women fight flu virus better than men

Common mortality causes prevail in epilepsy patients

Antivirulence antibiotics could evade resistance longer than traditional antibiotics

Specialized oral nutrition supplement associated with 50% lower death rate in older patients

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Cold, Flu & Cough News and Research

Latest Cold, Flu & Cough News and Research

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Newsletters you may be interested in